Navigation Links
New Workers' Compensation Resource Guide Available For Pennsylvania Employers
Date:4/29/2008

PITTSBURGH, April 29 /PRNewswire/ -- One of the most significant expenses incurred by Pennsylvania employers is the cost of workers' compensation insurance driven by claims made against their business. In an effort to help Pennsylvania employers contain their workers' compensation exposure and control costs, the Pittsburgh based law firm of Fried, Kane, Walters, Zuschlag and Grochmal has published The 2008 Employers' Guide to Pennsylvania's Workers' Compensation Law.

Designed to equip Pennsylvania employers with the tools necessary to control their increasing workers' compensation costs, The 2008 Employers' Guide to Pennsylvania's Workers' Compensation Law provides a brief introduction to the Pennsylvania Workers' Compensation Act, discusses the employer's duties in reference to the workers' compensation law, explains how a Pennsylvania workers' compensation claim works, outlines the litigated workers' compensation case, offers suggestions of cost effective strategies employers can use to handle a workers' compensation issue, and discusses the remedies available to the employer to alter an injured worker's benefit status.

Fried, Kane's managing partner Michael Sherman said "There are limited resources available to employers to assist in navigating the highly technical and complex Pennsylvania Workers' Compensation Act. We are working to fill that void, by providing information which is essential to businesses with a proactive and strategic plan to manage work injury claims."

Attorney Dale Cable, a partner in the firm, observed that business owners need to concentrate on increasing revenues and growing their business. He said "Knowledge of the Pennsylvania Workers' Compensation Act is an integral part of business management resulting in controlled costs and a positive impact on the bottom line. The 2008 Employers' Guide to Pennsylvania's Workers' Compensation Law provides business owners, executives, risk managers and claims personnel a vi
'/>"/>

SOURCE Fried, Kane, Walters, Zuschlag & Grochmal
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Workers Memorial Day Event to Stage Mock Public Funeral Procession to Pay Tribute to Fallen Workers
2. Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base
3. Video: 18th Annual Retirement Confidence Survey(R): Health Care, Economy Major Concerns in Workers Record Drop in Retirement Confidence
4. Social Workers Honor William C. Bell with the International Rhoda G. Sarnat Award
5. SEIU Seeks Damages for CNAs Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics
6. Review Urges Aggressive MRSA Screening for Health Workers
7. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
8. SEIU Members Stand Up for the Future of the Labor Movement and the Interests of All Workers
9. Coastal Communities Hospital Workers Join United Healthcare Workers
10. Jackson Hewitt(R) Celebrates Healthcare Workers With Occupation-Based Tax Savings
11. North County Caregivers Join United Healthcare Workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...ncephalitis this year has been confirmed in a nine... health officials the boy is seriously ill and has... John Fontaine. Middleborough was included in the...rial spraying on August eighth to kill the virus c...
... hospital in the capital were restored and most ho...he cessation of the strike by resident doctors. Th...University, Indraprastha University, called off th...e reservation bill to the Parliament’s Standing Co...
...d the Northern Territory Government’s decision to ...couraged other jurisdictions to follow suit and he...y disease. The NT’s decision came after the Federa...s Advisory Committee (PBAC) concluded that it woul...
...gland Journal of Medicine states that skin infecti...// . Gregory Moran the lead author of the study, ...ys, “MRSA, has become the leading cause of such in...oms.” He further mentioning that, it now accounts ...
Other Medicine News:Health News:MRSA Fast Becoming The Leading Cause Of Skin Infections 2
(Date:9/3/2008)...ber is National Vascular Disease Awareness Month, ...fusion Pharmaceuticals,LLC, a clinical-stage drug-...the treatment of unmet medical needs, announced to...e I/II clinical trial of its lead drug,candidate t...ed NCT00725881,on the clinicaltrials.gov Website, ...
(Date:9/3/2008)... Md., Sept. 3 /- Panacea Pharmaceutic...ent Number 7,413,737 covering,antibodies against h...), a,proprietary human cancer biomarker and therap...ollaboration with the Massachusetts Institute of,T...de rights to this patent,for development of human ...
(Date:9/3/2008)...Company to Discuss Phase 3 Plans with FDA, PRINCE...ics, Inc.,announced today that it successfully co... of the company,s new, innovative low-dose, once-w...rs to by its internal product,code AG-200-15. The ...t its,primary endpoint of ovulation suppression, c...
(Date:9/3/2008)...rial Reconfirms Strong Evidence Pycnogenol(R) Lowe...ect on Joints Following Cessation ...3 /- According to the Center for,Dise... type of arthritis,is on the rise. A new study pu...arch, reveals Pycnogenol(R), bark extract from the...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 1Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 2Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 3Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 4Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 1Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 2Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 3Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 4R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 1R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 1Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 3
...Lymphoma Reported,Today at ASCO Annual Meeting, PH...thKline plc,announced today long-term efficacy dat...e of frontline treatment with the BEXXAR(R),Therap...momab) in,76 patients with newly diagnosed advance...gimen was found to induce durable clinical,and mol...
...e/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnolog... a historic landmark in medical oncology and a,def...gene therapy.,The first clinical report of its kin...ue of the International Journal of,Oncology, Vol.3...res of tumor destruction observed in chemo-resista...
Other Medicine Technology:8-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
Tank Blotting System. Designed for Western, Northern, or Southern Blotting. Transfer up to three gels with dimensions as large as 15cm x 21.5cm. Includes and internal cooling base for temperature
... proven electrophoretic transfer apparatus incorpo...ltimate in field uniformity. Its design allows for... when coupled with a low voltage power source such...ts/cm. The result is exceptionally rapid and exact...
...lot cell, a component of Bio-Rad's modular mini el...resis Systems), provides rapid, high-quality blott...ransfers two 7.5 x 10 cm gels in just 1 hour. Cool... absorbs heat generated during transfers. The Mini...
Includes PowerPac 200 power supply. Flexibility for a Range of Parameters. Quantitative Transfers. Native Enzyme, High Intensity, or Overnight Transfers. Faster, Higher-Efficiency Transfers via Pl
Medicine Products: